1. Home
  2. CNTN vs QSI Comparison

CNTN vs QSI Comparison

Compare CNTN & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.00

Market Cap

146.5M

Sector

Health Care

ML Signal

N/A

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.74

Market Cap

165.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
QSI
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.5M
165.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CNTN
QSI
Price
$2.00
$0.74
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$1.00
AVG Volume (30 Days)
700.3K
2.7M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
88.10
28.17
EPS
N/A
N/A
Revenue
N/A
$2,436,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$618.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$0.69
52 Week High
$5.27
$3.10

Technical Indicators

Market Signals
Indicator
CNTN
QSI
Relative Strength Index (RSI) 44.48 42.45
Support Level $1.75 $0.69
Resistance Level $3.80 $1.04
Average True Range (ATR) 0.13 0.05
MACD 0.04 0.01
Stochastic Oscillator 77.94 26.14

Price Performance

Historical Comparison
CNTN
QSI

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: